245
Views
8
CrossRef citations to date
0
Altmetric
Articles

Molecular docking and 3D-QSAR studies on the glucocorticoid receptor antagonistic activity of hydroxylated polychlorinated biphenyls

, , , &
Pages 87-99 | Received 22 Sep 2015, Accepted 16 Dec 2015, Published online: 05 Feb 2016

References

  • S.M. Dickerson, S.L. Cunningham, and A.C. Gore, Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus, Toxicol. Appl. Pharm. 252 (2011), pp. 36–46.
  • S. Safe, Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): Biochemistry, toxicology, and mechanism of action, Crit. Rev. Toxicol. 13 (1984), pp. 319–395.
  • D.C. Morse, E.K. Wehler, M. Vandepas, A. Debie, P.J. Vanbladeren, and A. Brouwer, Metabolism and biochemical effects of 3,3',4,4'-tetrachlorobiphenyl in pregnant and fetal rats, Chem.-Biol. Interact. 95 (1995), pp. 41–56.
  • B. Gomara, M. Athanasiadou, J. Eduardo Quintanilla-Lopez, M. Jose Gonzalez, and A. Bergman, Polychlorinated biphenyls and their hydroxylated metabolites in placenta from Madrid mothers, Environ. Sci. Pollut. Res. 19 (2012), pp. 139–147.
  • J. Bytingsvik, E. Lie, J. Aars, A.E. Derocher, O. Wiig, and B.M. Jenssen, PCBs and OH-PCBs in polar bear mother-cub pairs: A comparative plasma levels in 1998 and 2008, Sci. Total Environ. 417 (2012), pp. 117–128.
  • I. Meerts, Y. Assink, P.H. Cenijn, J.H.J. van den Berg, B.M. Weijers, A. Bergman, J.H. Koeman, and A. Brouwer, Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat, Toxicol. Sci. 68 (2002), pp. 361–371.
  • D.D. Vakharia and J.F. Gierthy, Use of a combined human liver microsome-estrogen receptor binding assay to assess potential estrogen modulating activity of PCB metabolites, Toxicol. Lett. 114 (2000), pp. 55–65.
  • S. Kitamura, N. Jinno, T. Suzuki, K. Sugihara, S. Ohta, H. Kuroki, and N. Fujimoto, Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture, Toxicology 208 (2005), pp. 377–387.
  • S. Takeuchi, F. Shiraishi, S. Kitamura, H. Kuroki, K. Jin, and H. Kojima, Characterization of steroid hormone receptor activities in 100 hydroxylated polychlorinated biphenyls, including congeners identified in humans, Toxicology 289 (2011), pp. 112–121.
  • M. Spreafico, B. Ernst, M.A. Lill, M. Smiesko, and A. Vedani, Mixed-model QSAR at the glucocorticoid receptor: Predicting the binding mode and affinity of psychotropic drugs, ChemMedChem 4 (2009), pp. 100–109.
  • S. Arulmozhiraja, F. Shiraishi, T. Okumura, M. Iida, H. Takigami, J.S. Edmonds, and M. Morita, Structural requirements for the interaction of 91 hydroxylated polychlorinated biphenyls with estrogen and thyroid hormone receptors, Toxicol. Sci. 84 (2005), pp. 49–62.
  • X. Li, J. Fu, W. Shi, Y. Luo, X. Zhang, H. Zhu, and H. Yu, 3D-QSAR and molecular docking studies on benzotriazoles as antiproliferative agents and histone deacetylase inhibitors, Bull. Korean Chem. Soc. 34 (2013), p. 2387.
  • X. Li, L. Ye, X. Wang, X. Wang, H. Liu, X. Qian, Y. Zhu, and H. Yu, Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on estrogenic activity of hydroxylated polychlorinated biphenyls, Sci. Total Environ. 441 (2012), pp. 230–238.
  • X. Li, L. Ye, W. Shi, H. Liu, C. Liu, X. Qian, Y. Zhu, and H. Yu, In silico study on hydroxylated polychlorinated biphenyls as androgen receptor antagonists, Ecotoxicol. Environ. Saf. 92 (2013), pp. 258–264.
  • Q. Lu, Z. Cai, J. Fu, S. Luo, C. Liu, X. Li, and D. Zhao, Molecular docking and molecular dynamics studies on the interactions of hydroxylated polybrominated diphenyl ethers to estrogen receptor alpha, Ecotoxicol. Environ. Saf. 101 (2014), pp. 83–89.
  • M. Clark, R.D. Cramer, and N. Vanopdenbosch, Validation of the general-purpose Tripos 5.2 force field, J. Comput. Chem. 10 (1989), pp. 982–1012.
  • A.N. Jain, Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search, J. Comput.-Aided Mol. Des. 21 (2007), pp. 281–306.
  • G.A. Schoch, B. D'Arcy, M. Stihle, D. Burger, D. Bär, J. Benz, R. Thoma, and A. Ruf, Molecular switch in the glucocorticoid receptor: Active and passive antagonist conformations, J. Mol. Biol. 395 (2010), pp. 568–577.
  • J. Fu, Y. Yang, X. Zhang, W. Mao, Z. Zhang, and H. Zhu, Discovery of 1H-benzo [d][1, 2, 3] triazol-1-yl 3, 4, 5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase, Bioorg. Med. Chem. 18 (2010), p. 8457.
  • J.L. Liu, F.F. Wang, Z. Ma, X. Wang, and Y.H. Wang, Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods, Int. J. Mol. Sci. 12 (2011), pp. 946–970.
  • R.X. Wang, Y.P. Lu, and S.M. Wang, Comparative evaluation of 11 scoring functions for molecular docking, J. Med. Chem. 46 (2003), pp. 2287–2303.
  • X.-L. Shen, M. Takimoto-Kamimura, J. Wei, and Q.-Z. Gao, Computer-aided de novo ligand design and docking/molecular dynamics study of vitamin D receptor agonists, J. Mol. Model. 18 (2012), pp. 203–212.
  • M. Hao, Y. Li, Y. Wang, Y. Yan, and S. Zhang, Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation, J. Chem. Inf. Model. 51 (2011), pp. 2560–2572.
  • J. Diao, Y. Li, S. Shi, Y. Sun, and Y. Sun, QSAR models for predicting toxicity of polychlorinated dibenzo-p-dioxins and dibenzofurans using quantum chemical descriptors, Bull. Environ. Contam. Toxicol. 85 (2010), pp. 109–115.
  • Y.W. Wang, H.X. Liu, C.Y. Zhao, Z.W. Cai, and G.B. Jiang, Quantitative structure–activity relationship models for prediction of the toxicity of polybrominated diphenyl ether congeners, Environ. Sci. Technol. 39 (2005), pp. 4961–4966.
  • K.M. Gilbert, T.L. Boos, C.M. Dersch, E. Greiner, A.E. Jacobson, D. Lewis, D. Matecka, T.E. Prisinzano, Y. Zhang, R.B. Rothman, K.C. Rice, and C.A. Venanzi, DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods, Bioorg. Med. Chem. 15 (2007), pp. 1146–1159.
  • K.E. Hevener, D.M. Ball, J.K. Buolamwini, and R.E. Lee, Quantitative structure–activity relationship studies on nitrofuranyl anti-tubercular agents, Bioorg. Med. Chem. 16 (2008), pp. 8042–8053.
  • W. Yang, X. Liu, H. Liu, Y. Wu, J.P. Giesy, and H. Yu, Molecular docking and comparative molecular similarity indices analysis of estrogenicity of polybrominated diphenyl ethers and their analogues, Environ. Toxicol. Chem. 29 (2010), pp. 660–668.
  • G.H.G. Trossini, R.V.C. Guido, G. Oliva, E.I. Ferreira, and A.D. Andricopulo, Quantitative structure–activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: Molecular modeling, CoMFA and CoMSIA studies, J. Mol. Graph. Model. 28 (2009), pp. 3–11.
  • Y. Yang, J. Qin, H. Liu, and X. Yao, Molecular dynamics simulation, free energy calculation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors, J. Chem. Inf. Model. 51 (2011), pp. 680–692.
  • V.D. Mouchlis, G. Melagraki, T. Mavromoustakos, G. Kollias, and A. Afantitis, Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: An integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA, J. Chem. Inf. Model. 52 (2012), pp. 711–723.
  • C.K. Ryu, Y. Lee, S.G. Park, H.J. You, R.Y. Lee, S.Y. Lee, and S. Choi, 3D-QSAR studies of heterocyclic quinones with inhibitory activity on vascular smooth muscle cell proliferation using pharmacophore-based alignment, Bioorg. Med. Chem. 16 (2008), pp. 9772–9779.
  • H. Zhu, L. Ye, A. Richard, A. Golbraikh, F.A. Wright, I. Rusyn, and A. Tropsha, A novel two-step hierarchical quantitative structure-activity relationship modeling work flow for predicting acute toxicity of chemicals in rodents, Environ. Health Perspect. 117 (2009), pp. 1257–1264.
  • F. Li, X. Liu, L. Zhang, L. You, H. Wu, X. Li, J. Zhao, and J. Yu, QSAR studies on the depuration rates of polycyclic aromatic hydrocarbons, polybrominated diphenyl ethers and polychlorinated biphenyls in mussels (Elliptio complanata), SAR QSAR Environ. Res. 22 (2011), pp. 561–573.
  • A. Golbraikh and A. Tropsha, Beware of q2!, J. Mol. Graph. Model. 20 (2002), pp. 269–276.
  • S.Y. Liao, L. Qian, T.F. Miao, H.L. Lu, and K.C. Zheng, CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity, Eur. J. Med. Chem. 44 (2009), pp. 2822–2827.
  • K.H. Hyun, D.Y. Lee, B.-S. Lee, and C.K. Kim, Receptor-based 3D QSAR studies on PPARγ agonists using CoMFA and CoMSIA approaches, QSAR Comb. Sci. 23 (2004), pp. 637–649.
  • C. Kunick, K. Lauenroth, K. Wieking, X. Xie, C. Schultz, R. Gussio, D. Zaharevitz, M. Leost, L. Meijer, A. Weber, F.S. Jørgensen, and T. Lemcke, Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones, J. Med. Chem. 47 (2004), pp. 22–36.
  • F. Cao, X. Li, L. Ye, Y. Xie, X. Wang, W. Shi, X. Qian, Y. Zhu, and H. Yu, Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on the aryl hydrocarbon receptor agonistic activity of hydroxylated polychlorinated biphenyls, Environ. Toxicol. Pharmacol. 36 (2013), pp. 626–635.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.